Article Summary
苏保雄,梁 璐,方 瑜,葛繁梅,汪梅花,冯延丽.髓细胞性白血病患儿PTEN蛋白表达及其与免疫表型的关系[J].现代生物医学进展英文版,2019,19(10):1953-1957.
髓细胞性白血病患儿PTEN蛋白表达及其与免疫表型的关系
Expression of PTEN Protein and Its Relationship with Immunophenotype in Children with Myeloid Leukemia
Received:September 24, 2018  Revised:October 18, 2018
DOI:10.13241/j.cnki.pmb.2019.10.032
中文关键词: 髓细胞性白血病  PTEN蛋白  免疫表型  相关性
英文关键词: Myeloid leukemia  PTEN protein  Immunophenotype  Correlation
基金项目:陕西省中医管理局中医药科研项目(JCMS036)
Author NameAffiliationE-mail
SU Bao-xiong Department of hematology, affiliated hospital of Yan 'an university in Shaanxi province, Yan'an, Shaanxi, 716000, China Subaoxiong42378@163.com 
LIANG Lu Department of anesthesiology, affiliated hospital of Yan 'an university in Shaanxi province, Yan'an Shaanxi, 716000, China  
FANG Yu Diagnostics teaching and research section, Shaanxi University Of Chinese Medicine, Xianyang, Shaanxi, 712046, China  
GE Fan-mei Department of hematology, affiliated hospital of Yan 'an university in Shaanxi province, Yan'an, Shaanxi, 716000, China  
WANG Mei-hua Department of hematology, affiliated hospital of Yan 'an university in Shaanxi province, Yan'an, Shaanxi, 716000, China  
FENG Yan-li Department of hematology, affiliated hospital of Yan 'an university in Shaanxi province, Yan'an, Shaanxi, 716000, China  
Hits: 803
Download times: 598
中文摘要:
      摘要 目的:探讨髓细胞性白血病(AML)患儿PTEN蛋白表达及其与免疫表型的关系。方法:选择AML患儿143例,根据免疫表型的不同分为两组:免疫分型为LY+AML型59例,LY-AML84例。所有患儿都给予免疫表型分析,检测PTEN蛋白表达情况并进行相关性分析。结果:LY+AML患儿CD34+阳性、CD117+阳性比例显著高于LY-AML患儿(P <0.05),染色体核型异常比例显著低于LY-AML患儿(P <0.05)。LY+AML患儿的PTEN蛋白表达量为(65.33±2.34)%,阳性表达率为94.9%;而LY-AML分别为(20.11±4.11)%和13.1%,与LY+AML患儿对比差异都有统计学意义(P <0.05)。在AML患儿中,Spearman相关分析显示PTEN蛋白表达水平与免疫分型呈现显著相关性(r =0.653,P =0.000)。多因素logistic回归方法显示PTEN蛋白表达、CD34+阳性、CD117+阳性、染色体核型异常为影响AML患儿免疫表型的主要独立危险因素(OR=1.098、1.045、1.092、0.294,P <0.05)。结论:AML患儿骨髓单个核细胞的PTEN蛋白表达上调使得LY+AML型发生风险显著增加,可作为AML患儿病情判断与预后预测的参考指标之一。
英文摘要:
      ABSTRACT Objective: To investigate the expression of PTEN protein and its relationship with immunophenotype in children with acute myeloid leukemia (AML). Methods: 143 children with AML were selected. According to the different of immunophenotype, they were divided into two groups: 59 cases of LY+AML type and 84 cases of LY-AML. All the children were given immunophenotypic analysis, and the expression of PTEN protein were detected and given the correlation analysis. Results: The proportion of CD34+ positive and CD117+ positive in children with LY+AML were significantly higher than that in children with LY-AML (P <0.05), and the abnormal proportion of karyotype were significantly lower than that in children with LY-AML (P <0.05). The expression of PTEN protein in children with LY+AML were (65.33±2.34)%, and the positive expression rates were 94.9%. The LY-AML were (20.11±4.11)% and 13.1%, respectively, compared he difference were statistically significant in children with LY+AML(P <0.05). In children with AML, Spearman correlation analysis showed a significant correlation between PTEN protein expression and immunophenotyping (r =0.653, P=0.000). Multivariate logistic regression showed that PTEN protein expression, CD34+ positive, CD117+ positive, and karyotypic abnormalities were the main independent risk factors affected the immunophenotype of children with AML(OR =1.098, 1.045, 1.092, 0.294, P<0.05). Conclusion: The upregulation of PTEN protein expression in the bone marrow mononuclear cells can significantly increase the risk of LY+AML. It can be used as the reference index of the prognosis of children with AML.
View Full Text   View/Add Comment  Download reader
Close